Target intelligence / Profile preview

PRAME family member 26 (PRAMEF26)

Target
PRAMEF26
Molecular classification
Other, Leucine-rich repeat protein
01

Overview

PRAME family member 26 (PRAMEF26) is a human protein-coding gene belonging to the PRAME family, characterized by leucine-rich repeats associated with protein-protein interactions[1][6]. PRAMEF26 is predicted to act as a substrate adaptor within Cullin2-RING E3 ubiquitin ligase complexes, potentially facilitating proteasome-mediated degradation of target proteins in the cytoplasm[2]. Its molecular function and involvement in disease remain largely uncharacterized, and there is no published evidence indicating PRAMEF26's use as a receptor, drug target, or biomarker[2][3][6]. Key distinctions and clarifications: - PRAMEF26 is not the same as PRAME (preferably used for the well-characterized cancer antigen). - PRAMEF26 is a substrate-adaptor protein, not a receptor, enzyme, transporter, channel, or transcription factor[2][6]. - No disease or drug involvement specific to PRAMEF26 is documented. - Nomenclature is correct per standard genomic sources (HGNC; GeneCards; UniProt)[2][6]. If more detailed, structured, or mechanistic biological information is required, future research may be necessary, as current knowledge is limited to predicted roles.

Other names
PRAMEF26PRAMEF25Putative PRAME family member 26
02

Biological functions

Proteasome-mediated ubiquitin-dependent protein catabolic processPotential role in protein substrate recognition for degradationOther
03

Disease associations

Other

Beyond the preview

Go deeper on PRAME family member 26 (PRAMEF26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRAME family member 26 (PRAMEF26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call